Deep product pipeline of T2MR applications in development
T2 Biosystems has multiple applications currently in development that may enable breakthroughs in providing more rapid and accurate therapy to patients. All are focused on high-value healthcare ailments where solutions can serve a dual role: saving lives while reducing costs. Due to T2MR technology's advantage of detecting directly from patient blood samples, there is an opportunity for significant clinical advantages and market impact.
In addition to our FDA-cleared T2Candida Panel and T2Dx Instrument, and T2Bacteria™ Panel for Research Use Only, new products in the pipeline include additional sepsis, hemostasis and Lyme disease applications.